SEATTLE, Jan. 26, (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company pioneering a single-molecule protein analysis. Do Insiders Own Lots Of Shares In Nautilus Biotechnology, Inc. (NASDAQ:NAUT)?. (Simply Wall St.) Sep AM. Nautilus Biotechnology market cap as of August 30, is $B. Compare NAUT With Other Stocks. 14, (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform. Stock analysis for Nautilus Biotechnology Inc (NAUT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company.
Nautilus Biotechnology's latest funding round was a Corporate Minority - P2P for $M on July 28, Nautilus Biotechnology's valuation in June was. The current market capitalization of Nautilus Biotechnology is $M. What is Nautilus Biotechnology's annual earnings per share (EPS)?. Nautilus. NAUT | Complete Nautilus Biotechnology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Nautilus Biotechnology, Inc. (NAUT): $ · Get Rating · Component Grades · Latest NAUT News From Around the Web. Track Nautilus Biotechnology Inc (NAUT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Is Nautilus Biotechnology, Inc. stock A Buy? Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current. Nautilus Biotechnology Inc. ; 12 Month Change. % ; Day Range - ; 52 Wk Range - ; Volume, 70K ; Market Value, $M. NAUTILUS BIOTECHNOLOGY, INC. NAUT | stock. $ %. $ M. %. $ - Exchanges: NASDAQ. Sector: Health Care. Industry: Biotech Pharma. No company. According to Nautilus Biotechnology's latest financial reports and stock price the company's current number of shares outstanding is ,, At the end of. Find out the direct holders, institutional holders and mutual fund holders for Nautilus Biotechnology, Inc. (NAUT). Nautilus Biotechnology market cap as of August 30, is $B. Compare NAUT With Other Stocks.
Track Nautilus Biotechnology Inc (NAUT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Find the latest Nautilus Biotechnology, Inc. (NAUT) stock quote, history, news and other vital information to help you with your stock trading and. Historical stock prices. Current Share Price, US$ 52 Week High, US$ 52 Week Low, US$ Beta, 11 Month Change, %. SEATTLE, Jan. 26, (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company pioneering a single-molecule protein analysis. Nautilus Biotechnology, Inc.'s stock symbol is NAUT and currently trades under NASDAQ. It's current price per share is approximately $ Consensus Rating. Nautilus Biotechnology has received a consensus rating of Moderate Buy. The company's average rating score is , and is based on 1 buy. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today announced the company will participate in the Morgan. Discover real-time Nautilus Biotechnolgy, Inc. Common Stock (NAUT) stock prices, quotes, historical data, news, and Insights for informed trading and. View the NAUT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Nautilus Biotechnology.
News for Nautilus Biotechnology Stock (NAUT) · Nautilus Biotechnology, Inc. · Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year Financial Results. Key Stats · Market CapM · Shares OutM · 10 Day Average VolumeM · Dividend- · Dividend Yield- · Beta · YTD % Change Nautilus Biotechnology Shares Are Trading Higher After Guggenheim Initiated Coverage on the Stock With a Buy Rating and a $6 Price Target. Nautilus Biotechnology Inc. is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Nautilus Biotechnology Inc.'s. The biotech company Nautilus Biotechnology Inc trades as NAUT stock on the Nasdaq All Markets. Nautilus (Nasdaq: NAUT) is a company with a vision to.
Jeff Bezos invested into this Biotech Stock! Should you? Genomics - SPAC - Nautilus Biotechnology
NAUT's current price target is $ Learn why top analysts are making this stock forecast for Nautilus Biotechnology at MarketBeat. Number of Insider Shares Traded ; Last Date · Shares Traded. Price. Shares Held ; 3/11/ · 12, $ 10,, ; 3/08/ · 2, $ 10,,
How To Check If Someone Is A Police Officer | Why Are Stocks Up